Covid-19 case statistics
Pro Research Analysisby 
Searched over 200M research papers
COVID-19 Case Statistics: Incidence, Fatality, and Recovery Rates
Case Incidence and Growth Rates
COVID-19 spread rapidly across the globe, with early data showing significant differences in incidence and growth rates between countries and regions. In Europe, the standardized case-increase rate was about 5%, with the highest rates observed in Belgium, Sweden, Russia, the Netherlands, and the United Kingdom. However, the average case-increase rate began to decline by around 3% weekly as of May 2020, indicating some success in containment efforts . In the United States, estimates suggest that by the end of September 2020, there were approximately 52.9 million total infections, with 44.8 million symptomatic illnesses and 2.4 million hospitalizations, highlighting the large gap between reported and actual cases due to under-detection . In Bangladesh, incidence rates varied widely across districts, with hotspots identified in Dhaka and surrounding areas, and a strong correlation between population density and case frequency .
Case Fatality Rates (CFR) and Hospitalization Outcomes
Case fatality rates (CFR) varied significantly by country and over time. In Europe, the CFR was estimated at 4–4.5% as of May 2020, with some countries like Belgium, the Netherlands, and Sweden experiencing higher rates . In Italy, the CFR reached 13.3% in early April 2020, much higher than South Korea (1.8%) and China (4%) . In Bangladesh, the CFR was reported at 1.4% . A systematic review of hospitalized patients found an overall mortality rate of 17.1%, with 11.5% for general hospital admissions and 40.5% among critical care cases . In the UK, among 20,133 hospitalized patients, 26% died, and mortality was higher among older adults, men, and those with comorbidities .
Recovery Rates and Disease Severity
Recovery rates also showed regional variation. In Europe, the average case-recovery rate was 46% as of May 2020, with little increase observed over time . Globally, more than 80% of COVID-19 cases were mild, about 14% developed severe complications, and 5% were classified as critical . Time series models have been used to forecast both confirmed and recovered cases, aiding in healthcare planning and resource allocation .
Transmission Dynamics and Clustering
The basic reproduction number (R0) was estimated to be between 2 and 3 in Italy and 2.5 to 4 in Spain, indicating high transmissibility in the early stages of the outbreak . Spatial analyses in the US and Bangladesh identified significant clusters and hotspots, with urban centers and densely populated areas experiencing the highest case concentrations 69. The distribution of confirmed cases and deaths followed a power-law, with most cases concentrated in a few epicenters, especially during the initial phase of the pandemic .
Conclusion
COVID-19 case statistics reveal substantial variation in incidence, fatality, and recovery rates across different countries and regions. While the rate of new cases began to decline in some areas, fatality rates remained high, especially among hospitalized and critically ill patients. Recovery rates improved slowly, and the majority of cases were mild, but severe and critical cases placed a significant burden on healthcare systems. Understanding these statistics and their spatial patterns is crucial for effective public health planning and response 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic
Increase in COVID‐19 cases and case‐fatality and case‐recovery rates in Europe: A cross‐temporal meta‐analysis
The COVID-19 case-increase rate in Europe has dropped, but case-fatality rates remain high, with a minimum of 4 weeks needed to reduce the fatality rate to 1%.
Understanding epidemic data and statistics: A case study of COVID‐19
COVID-19 has affected 181 countries, with lockdown policies in China, Italy, and Spain significantly reducing cases, while reducing working hours in Iran and South Korea.
Estimated incidence of COVID-19 illness and hospitalization — United States, February–September, 2020
COVID-19 may have caused 2.4 million hospitalizations, 44.8 million symptomatic illnesses, and 52.9 million total infections in the U.S. from February 27-September 30, 2020.
DOI